Simplify Logo

Full-Time

Associate Director

Field Medical Affairs, Alzheimer’s Disease Agitation

Posted on 3/29/2024

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for central nervous system conditions

Hardware
Biotechnology

Compensation Overview

$190k - $215kAnnually

+ Bonus + Equity

Senior

Remote in USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • Advanced degree: MD, PharmD, or PhD required
  • At least 7 years of MSL experience; MSL management experience a plus
  • Training and /or work experience in Alzheimer required
  • Preference for candidates with launch experience
  • Ability to travel up to 75%, including overnight stays and weekend, as needed
  • Meet requirements for health industry representative credentialing to gain access to healthcare facilities
Responsibilities
  • Systematically identify and develop relationships with Healthcare Professionals (HCPs)
  • Provide fair and balanced scientific information to HCPs and internal business partners
  • Lead scientific discovery and communicate meaningful insights gleaned from peer-to-peer discussions with HCPs
  • Identify, analyze, and translate specific needs to achieve clinical and business objectives
  • Collaborate with internal partners to advance clinical and business objectives
  • Maintain technical and clinical expertise in Agitation in Alzheimer disease and across other neuroscience therapeutic areas
  • Maintain knowledge base of global and regional market issues, trends, and treatments
  • Contribute to the growth and development of the Field Medical Team
  • Execute key job functions, including documentation of field activities, submission of medical insights, completion of medical information requests, expense report submission, required trainings, and other tasks
  • Provide high level support for company sponsored trials and aide in navigating investigator-initiated research proposals through the review process
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

With a dedicated focus on developing therapies for central nervous system conditions—such as depression, Alzheimer’s disease agitation, and fibromyalgia—this company stands out by addressing critical unmet medical needs with promising products like AXS-05 and AXS-07. The firm fosters a culture deeply committed to innovation and the development of therapies with novel mechanisms of action, showcasing strong potential in the medical field and enhancing patient care in areas with limited treatment options.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

110%

1 year growth

110%

2 year growth

110%
INACTIVE